NEVPF
Price:
$0.028
Market Cap:
$715.67M
Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in...[Read more]
Industry
Biotechnology
IPO Date
2014-03-20
Stock Exchange
OTC
Ticker
NEVPF
According to Abliva AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -2.80. This represents a change of -11.32% compared to the average of -3.16 of the last 4 quarters.
The mean historical PE Ratio of Abliva AB (publ) over the last ten years is -2.16. The current -2.80 PE Ratio has changed 12.85% with respect to the historical average. Over the past ten years (40 quarters), NEVPF's PE Ratio was at its highest in in the September 2022 quarter at -1.15. The PE Ratio was at its lowest in in the March 2015 quarter at -26.26.
Average
-2.16
Median
-2.13
Minimum
-3.35
Maximum
0
Discovering the peaks and valleys of Abliva AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 95.43%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -3.35
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 0 | -100.00% |
| 2023 | -2.72 | 74.28% |
| 2022 | -1.56 | -15.12% |
| 2021 | -1.84 | -44.00% |
| 2020 | -3.28 | 6.92% |
| 2019 | -3.07 | 95.43% |
| 2018 | -1.57 | -29.36% |
| 2017 | -2.22 | 8.84% |
| 2016 | -2.04 | -39.04% |
| 2015 | -3.35 | -90.01% |
The current PE Ratio of Abliva AB (publ) (NEVPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.42
5-year avg
-1.88
10-year avg
-2.16
Abliva AB (publ)’s PE Ratio is greater than Medivir AB (publ) (-4.51), less than Relief Therapeutics Holding AG (-2.06), greater than Oncopeptides AB (publ) (-4.54), less than Small Pharma Inc. (-2.19), greater than Alpha Cognition Inc. (-8.68), greater than IntelGenx Technologies Corp. (-2.99), greater than Herantis Pharma Oyj (-9.37), greater than ImmuPharma plc (-7.71), greater than Mindset Pharma Inc. (-4.01), less than MedPeer,Inc. (10.16),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.51 | $45.78M | |
| -2.06 | $44.94M | |
| -4.54 | $55.98M | |
| -2.19 | $37.51M | |
| -8.68 | $35.66M | |
| -2.99 | $29.69M | |
| -9.37 | $59.47M | |
| -7.71 | $28.34M | |
| -4.01 | $54.51M | |
| 10.16 | $42.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abliva AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abliva AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Abliva AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Abliva AB (publ) (NEVPF)?
What is the highest PE Ratio for Abliva AB (publ) (NEVPF)?
What is the 3-year average PE Ratio for Abliva AB (publ) (NEVPF)?
What is the 5-year average PE Ratio for Abliva AB (publ) (NEVPF)?
How does the current PE Ratio for Abliva AB (publ) (NEVPF) compare to its historical average?